2. Inflammation/Immunology

Inflammation/Immunology

Inflammation/Immunology

Related Products

PDF 93.1 MB

The diseases caused by disorders of the immune system fall into two broad categories: immunodeficiency and autoimmunity. Immunotherapy is also often used in the immunosuppressed (such as HIV patients) and people suffering from other immune deficiencies or autoimmune diseases. This includes regulating factors such as IL-2, IL-10, IFN-α. Infection with HIV is characterized not only by development of profound immunodeficiency but also by sustained inflammation and immune activation. Chronic inflammation as a critical driver of immune dysfunction, premature appearance of aging-related diseases, and immune deficiency.

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-P4051
    HBV Seq1 aa:141-151 147318-53-4 98%
    HBV Seq1 aa:141-151 is a peptide. HBV Seq1 aa:141-151 can be used for the research of chronic hepatitis B virus (HBV) .
    HBV Seq1 aa:141-151
  • HY-P4055
    GP120, HIV-1 MN 98%
    GP120, HIV-1 MN is a peptide. GP120, HIV-1 MN can be used for the research of HIV infection.
    GP120, HIV-1 MN
  • HY-P4096
    HAP-1 329004-38-8 99.08%
    HAP-1 is a synovial-targeted transduction peptide. HAP-1 facilitates specific internalization of protein complexes into human and rabbit synovial cells. HAP-1 fused to an antimicrobial peptide, (KLAK)2, to generate a proapoptotic peptide DP2.
    HAP-1
  • HY-P4109
    vMIP-II (1-21) 265650-93-9 98%
    vMIP-II (1-21) (NT21MP) is an inhibitor of CXCR4. vMIP-II (1-21) interacts broadly with CC and CXC chemokine receptors. vMIP-II (1-21) inhibits CXCR4 by competing with 125I-SDF-1R for binding sites (IC50=190 nM).
    vMIP-II (1-21)
  • HY-P4110
    TAT-NSF222 Fusion Peptide 98%
    TAT-NSF222 Fusion Peptide is a fusion polypeptide with two domains, a TAT domain, which enters cells through macropinocytosis, and an NSF domain that inhibits N-ethylmaleimide-sensitive factor (NSF). TAT-NSF222 Fusion Peptide is an exocytosis inhibitor.
    TAT-NSF222 Fusion Peptide
  • HY-P4117
    Penetratin-Arg 474634-55-4 98%
    Penetratin-Arg is an antimicrobial and is used for drug delivery vehicle.
    Penetratin-Arg
  • HY-P4145
    Quazomotide 935395-33-8 98%
    Quazomotide is a WT1 class II peptide epitope with sequences of RSDELVRHHNMHQRNMTKL. Quazomotide stimulates a peptide-specific CD4(+) response, to recognize WT1(+) tumor cells. Quazomotide is an immunological agent for active immunization, as well as an antineoplastic agent.
    Quazomotide
  • HY-P4148
    Vorumotide 935395-34-9 98%
    Vorumotide is an immunological agent for active immunization as well as an antineoplastic agent.
    Vorumotide
  • HY-P4149
    Imsamotide 2130836-27-8 98%
    Imsamotide (IDO194-214) is a Indoleamine 2,3-Dioxygenase (IDO) peptide with sequences of DTLLKALLEIASCLEKALQVF, the IDO194-214. Imsamotide is also an immunological agent for active immunization, as well as an antineoplastic agent.
    Imsamotide
  • HY-P4151
    Marlumotide 952720-86-4 98%
    Marlumotide is an immunological agent for active immunization, as well as an antineoplastic agent.
    Marlumotide
  • HY-P4152
    Etimumotide 1431550-68-3 98%
    Etimumotide is an immunological agent for active immunization, as well as an antineoplastic agent.
    Etimumotide
  • HY-P4306
    Z-Phe-Phe-Diazomethylketone 65178-14-5 98%
    Z-Phe-Phe-Diazomethylketone is a selective inhibitor of cathepsin L.
    Z-Phe-Phe-Diazomethylketone
  • HY-P4357
    D-{Ala-Ala-Ala-Ala-Ala} 10491-09-5 98%
    D-{Ala-Ala-Ala-Ala-Ala} is a pentapeptide and can be used as an inhibitor of the immunological reactions.
    D-{Ala-Ala-Ala-Ala-Ala}
  • HY-P4535
    Ac-Trp-Glu-His-Asp-Aldehyde 189275-71-6 98%
    Ac-Trp-Glu-His-Asp-Aldehyde is a potent and selective caspase-1 inhibitor with a Ki value of 56 pM.
    Ac-Trp-Glu-His-Asp-Aldehyde
  • HY-P4628
    TPNQRQNVC 2022956-41-6 98%
    TPNQRQNVC is a nonapeptide and is the epitope of HLA-B0702. TPNQRQNVC induces a CD8+ T cell immune response.
    TPNQRQNVC
  • HY-P4664
    VHLTP 93913-38-3 98%
    VHLTP is the N-terminal pentapeptide of human hemoglobin beta. VHLTP binds to cell membranes and serves as a ligand for anti-HbA1c antibodies.
    VHLTP
  • HY-P4684
    Osteostatin 138949-73-2 98%
    Osteostatin, a fragment of parathyroid hormone-related protein (PTHrP) 107-111, promotes bone repair in animal models of bone defects and prevents bone erosion in inflammatory arthritis, inhibits collagen-induced arthritis and inhibits osteoclastic bone resorption directly. Osteostatin can be used for inflammation and immunology research.
    Osteostatin
  • HY-P4705
    Hymenistatin I 129536-23-8 98%
    Hymenistatin I is a cyclic octapeptide [c-(-Pro-Pro-Tyr-Val-Pro-Leu-Ile-ile-Ile-)] with immunosuppressive activity in both humoral and cellular immune responses.
    Hymenistatin I
  • HY-P4716
    Boc-D-Trp(For)-OH 64905-10-8 98%
    Boc-D-Trp(For)-OH, containing the amino acid tryptophan, is synthesized by the ammonolysis of Boc-protected D-alanine, followed by cyclization to form a dipeptide with ninhydrin. Boc-D-Trp(For)-OH has pharmacological properties, including inhibition of growth hormone release, induction of sleep and antiinflammatory.
    Boc-D-Trp(For)-OH
  • HY-P4720
    Interleukin-6 fragment (human) 145990-81-4 98%
    Interleukin-6 fragment (human) is a pleiotropic cytokine produced by lymphocytes and non-lymphocytes. The Interleukin-6 fragment (human) coding gene is located on human chromosome 7, with a length of approximately 5 kilobases. Interleukin-6 fragment (human) has potential applications in immune response, acute response, inflammation, tumors, and hematopoiesis.
    Interleukin-6 fragment (human)
Cat. No. Product Name / Synonyms Application Reactivity